Professor Emily Lancsar will use this seminar to run through a Keynote presentation she is giving at the Society for Benefit Cost Analysis international conference.

In that she will: discuss the role of economics and economic evaluation in health policy; the ways in which the application of economic evaluation in the health sector has differed to and in parts remained the same as the application of economic evaluation in public policy more broadly; and provide an overview of a program of work valuing health and human life, including the recent multi-national Preferences for Pandemic Preparedness study which quantified the value of life in a pandemic. Feedback welcome!

Bio

Emily is an economist with particular interests in valuing life and health, understanding and modelling choice, preferences and behaviour of key decision makers in the health sector, priority setting, economic evaluation and policy analysis.

Emily holds a number of current and past ARC, MRFF, NHMRC, MRC, ESRC, NIHR and EU funded grants and fellowships. She is a member of a number of government advisory committees including the Medical Services Advisory Committee (MSAC) and the Economic Sub-Committee of the Pharmaceutical Benefits Advisory Committee and was a member of the Evaluation Sub-Committee of MSAC from 2011-2021. She is an Associate Editor of Health Economics and a past Vice President of the Australian Health Economics Society.